Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POWDER: Topical Vancomycin for Open Fractures in the ER
NCT03765567Phase 4Recruiting
- Sponsor
- UT Health San Antonio
- Start
- Oct 2020
- Primary completion
- Sep 2027
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in open fracture, sponsored by UT Health San Antonio. Started Oct 2020; status: recruiting.
02
Drugs
vancomycin
03
Conditions
open fracture
Beyond the preview
Go deeper on NCT03765567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03765567.